AbbVie
ABBV
#30
Rank
NZ$530.26 B
Marketcap
$300.07
Share price
0.10%
Change (1 day)
20.91%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

EPS for AbbVie (ABBV)

EPS in 2023 (TTM): $5.98

According to AbbVie's latest financial reports the company's current EPS (TTM) is $6.37. In 2022 the company made an earnings per share (EPS) of $11.52 an increase over its 2021 EPS that were of $11.23.

EPS history for AbbVie from 2011 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$5.98-48.13%
2022$11.522.63%
2021$11.23125.21%
2020$4.99-45.69%
2019$9.1848.35%
2018$6.197.6%
2017$5.75-9.3%
2016$6.3415.48%
2015$5.49185.53%
2014$1.92-57.11%
2013$4.48-21.69%
2012$5.7355.73%
2011$3.68

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$3.22-49.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.87 7.86%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.40 47.51%๐Ÿ‡บ๐Ÿ‡ธ USA
$24.49 284.44%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.60 19.27%๐Ÿ‡บ๐Ÿ‡ธ USA
$31.95 401.54%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.06-4.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
$3.44-46.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
$3.39-46.75%๐Ÿ‡บ๐Ÿ‡ธ USA